Apoptosis in alcoholic and nonalcoholic steatohepatitis

Ariel E. Feldstein, Gregory James Gores

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

Alcohol liver disease (ALD) as well as nonalcoholic fatty liver disease (NAFLD) are two of the most common forms of chronic liver disease worldwide and may progress to cirrhosis and end stage liver disease. ALD and NAFLD seem to share many pathophysiologic mechanisms with the accumulation of lipids in the liver being the first step in the development of both conditions. While mitochondrial dysfunction and production of reactive oxygen species seem to play an important role in the progression from simple steatosis to steatohepatitis in both diseases, the pathogenesis of ALD and NAFLD as it relates to tissue injury remains poorly understood. Insights into these mechanisms are of significant clinical importance because current therapies for both conditions are limited and future therapies will be predicated by an understanding of their pathogenesis. In this review we focused on the current evidence for a central role of hepatocellular apoptosis, a specific form of cell death, in the pathogenesis of ALD and NAFLD as well as the current knowledge regarding the subcellular and molecular mechanisms involve in triggering hepatocyte apoptosis in these diseases.

Original languageEnglish (US)
Pages (from-to)3093-3099
Number of pages7
JournalFrontiers in Bioscience
Volume10
Issue numberSUPPL. 3
StatePublished - 2005

Fingerprint

Alcoholic Fatty Liver
Liver
Liver Diseases
Apoptosis
Alcohols
End Stage Liver Disease
Fatty Liver
Hepatocytes
Reactive Oxygen Species
Fibrosis
Chronic Disease
Cell Death
Non-alcoholic Fatty Liver Disease
Lipids
Wounds and Injuries
Therapeutics
Cell death

Keywords

  • Alcohol
  • Apoptosis
  • Bax
  • Fatty Acid
  • Hepatocyte
  • Lipoapoptosis
  • Liver
  • Review

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Apoptosis in alcoholic and nonalcoholic steatohepatitis. / Feldstein, Ariel E.; Gores, Gregory James.

In: Frontiers in Bioscience, Vol. 10, No. SUPPL. 3, 2005, p. 3093-3099.

Research output: Contribution to journalArticle

Feldstein, AE & Gores, GJ 2005, 'Apoptosis in alcoholic and nonalcoholic steatohepatitis', Frontiers in Bioscience, vol. 10, no. SUPPL. 3, pp. 3093-3099.
Feldstein, Ariel E. ; Gores, Gregory James. / Apoptosis in alcoholic and nonalcoholic steatohepatitis. In: Frontiers in Bioscience. 2005 ; Vol. 10, No. SUPPL. 3. pp. 3093-3099.
@article{22b470fd3c064beb82cb04ab8e73896a,
title = "Apoptosis in alcoholic and nonalcoholic steatohepatitis",
abstract = "Alcohol liver disease (ALD) as well as nonalcoholic fatty liver disease (NAFLD) are two of the most common forms of chronic liver disease worldwide and may progress to cirrhosis and end stage liver disease. ALD and NAFLD seem to share many pathophysiologic mechanisms with the accumulation of lipids in the liver being the first step in the development of both conditions. While mitochondrial dysfunction and production of reactive oxygen species seem to play an important role in the progression from simple steatosis to steatohepatitis in both diseases, the pathogenesis of ALD and NAFLD as it relates to tissue injury remains poorly understood. Insights into these mechanisms are of significant clinical importance because current therapies for both conditions are limited and future therapies will be predicated by an understanding of their pathogenesis. In this review we focused on the current evidence for a central role of hepatocellular apoptosis, a specific form of cell death, in the pathogenesis of ALD and NAFLD as well as the current knowledge regarding the subcellular and molecular mechanisms involve in triggering hepatocyte apoptosis in these diseases.",
keywords = "Alcohol, Apoptosis, Bax, Fatty Acid, Hepatocyte, Lipoapoptosis, Liver, Review",
author = "Feldstein, {Ariel E.} and Gores, {Gregory James}",
year = "2005",
language = "English (US)",
volume = "10",
pages = "3093--3099",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Apoptosis in alcoholic and nonalcoholic steatohepatitis

AU - Feldstein, Ariel E.

AU - Gores, Gregory James

PY - 2005

Y1 - 2005

N2 - Alcohol liver disease (ALD) as well as nonalcoholic fatty liver disease (NAFLD) are two of the most common forms of chronic liver disease worldwide and may progress to cirrhosis and end stage liver disease. ALD and NAFLD seem to share many pathophysiologic mechanisms with the accumulation of lipids in the liver being the first step in the development of both conditions. While mitochondrial dysfunction and production of reactive oxygen species seem to play an important role in the progression from simple steatosis to steatohepatitis in both diseases, the pathogenesis of ALD and NAFLD as it relates to tissue injury remains poorly understood. Insights into these mechanisms are of significant clinical importance because current therapies for both conditions are limited and future therapies will be predicated by an understanding of their pathogenesis. In this review we focused on the current evidence for a central role of hepatocellular apoptosis, a specific form of cell death, in the pathogenesis of ALD and NAFLD as well as the current knowledge regarding the subcellular and molecular mechanisms involve in triggering hepatocyte apoptosis in these diseases.

AB - Alcohol liver disease (ALD) as well as nonalcoholic fatty liver disease (NAFLD) are two of the most common forms of chronic liver disease worldwide and may progress to cirrhosis and end stage liver disease. ALD and NAFLD seem to share many pathophysiologic mechanisms with the accumulation of lipids in the liver being the first step in the development of both conditions. While mitochondrial dysfunction and production of reactive oxygen species seem to play an important role in the progression from simple steatosis to steatohepatitis in both diseases, the pathogenesis of ALD and NAFLD as it relates to tissue injury remains poorly understood. Insights into these mechanisms are of significant clinical importance because current therapies for both conditions are limited and future therapies will be predicated by an understanding of their pathogenesis. In this review we focused on the current evidence for a central role of hepatocellular apoptosis, a specific form of cell death, in the pathogenesis of ALD and NAFLD as well as the current knowledge regarding the subcellular and molecular mechanisms involve in triggering hepatocyte apoptosis in these diseases.

KW - Alcohol

KW - Apoptosis

KW - Bax

KW - Fatty Acid

KW - Hepatocyte

KW - Lipoapoptosis

KW - Liver

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=21344458172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344458172&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 3093

EP - 3099

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - SUPPL. 3

ER -